Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hookipa Pharma Inc

1.29
-0.0150-1.15%
Post-market: 1.290.00000.00%16:00 EDT
Volume:159.59K
Turnover:202.11K
Market Cap:15.72M
PE:-0.37
High:1.31
Open:1.31
Low:1.23
Close:1.31
Loading ...

Hookipa Pharma Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
16 Jun

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live
·
23 May

HOOKIPA to Sell HBV, HIV Program Assets to Gilead; Shares Rise

MT Newswires Live
·
23 May

Hookipa Pharma Inc. Announces Asset Sale Agreement with Gilead Sciences for HB-400 and HB-500 Programs

Reuters
·
22 May

HOOKIPA Pharma Q1 EPS $(1.23) Misses $(0.62) Estimate, Sales $2.00M Miss $3.38M Estimate

Benzinga
·
16 May

HOOKIPA Pharma Inc expected to post a loss of $1.04 a share - Earnings Preview

Reuters
·
05 May

Hookipa Pharma (HOOK) Receives a Hold from RBC Capital

TIPRANKS
·
04 Mar

BRIEF-Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger

Reuters
·
21 Feb

Poolbeg Pharma Plc - HOOKIPA Has Terminated Discussions on Proposed Combination of Two Companies

THOMSON REUTERS
·
21 Feb

Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial

TIPRANKS
·
30 Jan

HOOKIPA Pharma Inc - Primary Completion of Phase 1B Trial Expected H2 2025

THOMSON REUTERS
·
30 Jan

HOOKIPA Pharma Inc - Phase 1B Trial Evaluating Safety and Immunogenicity of Hb-500

THOMSON REUTERS
·
30 Jan

HOOKIPA Pharma Announces Enrollment Completion of Phase 1B Clinical Trial Evaluating Hb-500 for the Treatment of Hiv

THOMSON REUTERS
·
30 Jan

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

GlobeNewswire
·
30 Jan

Poolbeg Agrees to Bid Deadline Extension for Possible Hookipa Pharma Deal

Dow Jones
·
30 Jan

Hookipa Pharma (HOOK) was downgraded to a Hold Rating at Citi

TIPRANKS
·
12 Jan

HC Wainwright Downgrades HOOKIPA Pharma to Neutral From Buy

MT Newswires Live
·
10 Jan

HOOKIPA Pharma Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
10 Jan

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

GlobeNewswire
·
10 Jan

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.k. Disclosure Requirements

THOMSON REUTERS
·
08 Jan